8-K
filed May 7, 2026, 7:59 PM ET
ticker GOVX
CIK 0000832489
other material
confidence high
sentiment neutral
materiality 0.50
GeoVax raises ~$595k via warrant inducement; issues new warrants for 1M shares at $1.65
GeoVax Labs, Inc.
- Holders exercise warrants for 501,144 shares; gross proceeds ~$595k before fees.
- New warrants issued to purchase up to 1,002,288 shares at $1.65, exercisable after shareholder approval.
- Closing expected May 8, 2026; proceeds for working capital and general corporate purposes.
- New warrants issued in private placement under Regulation D; unregistered.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-26-015613
- form_type
- 8-K
- ticker
- GOVX
- cik
- 0000832489
- company_name
- GeoVax Labs, Inc.
- filed_at
- 2026-05-07T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:33.803408+00:00
- generated_at
- 2026-05-14T22:20:14.896548+00:00
- sec_items
- ["1.01", "3.02", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-26-015613
- json_url
- https://secwatch.observer/filing/0001437749-26-015613.json
- markdown_url
- https://secwatch.observer/filing/0001437749-26-015613.md
- text_url
- https://secwatch.observer/filing/0001437749-26-015613.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/832489/000143774926015613/0001437749-26-015613-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/832489/000143774926015613/govx20260507_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
CITR
CitroTech exchanges all Series A Preferred for Series C Convertible; BoltRock gets board rights
CitroTech Inc.
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
Comparable filing
On May 28, 2026, CitroTech Inc., a Wyoming corporation (the “Company”), entered into Stock Exchange and Stockholders Agreements (the “Exchange Agreements”) with the holders (the “Holders”) of the Company’s outstanding Series A Preferred Stock
Filing page
SEC filing
AIM
AIM ImmunoTech expects ~$4.2M gross from warrant inducement at $0.48/share; new warrants at $0.60
AIM ImmunoTech Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
Comparable filing
On May 7, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a warrant exercise inducement offer letter agreement (the “Inducement Letter”) with holders (the “Holders”) of (i) Class A and Class B common stock purchase warrants issued on May 31, 2024
Filing page
SEC filing
LTRX
Lantronix prices $30M common stock offering at $7.20/share; net proceeds ~$32.3M
LANTRONIX INC
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 7.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 9.01
same event type: other_material
similar materiality
This filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
Comparable filing
On May 29, 2026, Lantronix, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Needham & Company, LLC and Canaccord Genuity LLC, as underwriters (together, the “Underwriters”), pursuant to which the Company agreed to sell, and the Underwriters agreed to purchase, 4,166,667 shares (the “Firm Shares”) of the Company’s common stock
Filing page
SEC filing
CPSH
CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share
CPS TECHNOLOGIES CORP/DE/
June 1, 2026, 9:35 AM ET
other_material
Items 1.01, 5.03, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 9.01
same event type: other_material
similar materiality
This filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
Comparable filing
On May 27, 2026, CPS Technologies Corp. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with certain institutional investors (the “Investors”) for the sale by the Company of 1,200,000 shares (the “Shares”) of its Common Stock, par value $0.01 per share (“Common Stock”), in a registered direct offering (the “Offering”), at a purchase price of $8.00 per share.
Filing page
SEC filing
SNYR
Synergy CHC enters up to $36M equity purchase agreement with Hudson Global Ventures
Synergy CHC Corp.
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 9.01
same event type: other_material
similar materiality
This filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
Comparable filing
On May 8, 2026, Synergy CHC Corp. (the “Company”) entered into an equity purchase agreement (the “Purchase Agreement”) with Hudson Global Ventures, LLC (the “Investor”), pursuant to which the Company has the right, but not the obligation, to direct the Investor to purchase up to $36,000,000 of the Company’s common stock
Filing page
SEC filing
BNAI
BEN invests $1M in Accelevate, signs exclusive Mexico reseller and global deal
Brand Engagement Network Inc.
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 7.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 9.01
same event type: other_material
similar materiality
This filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
Comparable filing
On May 7, 2026, following the successful completion of due diligence, entered into two definitive Reseller Agreements (the “Commercial Agreements”) with Accelevate.
Filing page
SEC filing
AAT
AAT board raises Rady Trust ownership cap to 21.9%, lowers general limit to 6.775%
American Assets Trust, Inc.
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 9.01
same fact type: material_agreement
same SEC item: 1.01, 9.01
same event type: other_material
similar materiality
This filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
Comparable filing
On May 11, 2026, American Assets Trust, Inc. (the "Company") entered into a Voting Support Agreement (the "Voting Agreement") with the Ernest Rady Trust U/D/T March 10, 1983 (the "Rady Trust"), the Evelyn Shirley Rady Trust U/D/T March 10, 1983, and American Assets, Inc. (collectively, the "Stockholder").
Filing page
SEC filing
BBIO
BridgeBio Pharma establishes $500M at-the-market equity offering program
BridgeBio Pharma, Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 1.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 9.01
same event type: other_material
similar materiality
This filing
On May 7, 2026, GeoVax Labs Inc. (the “Company”), entered into common stock warrant exercise inducement offer letters (the “Inducement Letters”) with holders (the “Holders”) of existing warrants to purchase shares of the Company’s common stock
Comparable filing
On May 7, 2026, in connection with entering into the Agreement, the Company agreed with Goldman Sachs and Leerink Partners (formerly known as SVB Securities LLC), to terminate that certain Equity Distribution Agreement, dated May 4, 2023, by and among the Company, Goldman Sachs and Leerink Partners, effective as of May 7, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.